YOLFTbeta
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share

Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share

OACC · NASDAQ · Financial Services / Shell Companies

10.70USD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close10.70
Open10.70
Day Range10.70 – 10.70
52-Week Range10.47 – 10.88
Volume0
Market Cap265.00M
P/E (TTM)38.50
Forward P/E0.00
EPS0.28
Dividend Yield0.00%
50-Day Avg10.76
200-Day Avg10.68

About

Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.

Company Details

Leadership

  • Mr. Zaid PardesiCEO & Director · b. 1983
  • Mr. George A. MartinezCFO, Principal Accounting & Principal Financial Officer · b. 1985
  • Mr. Mathew M. PendoChief Operation Officer · b. 1964

Financials

Income Statement

Currency: USD2024-12-312025-12-31
Total Revenue-0
Operating Income-703-1.20M
EBITDA-351.81K-1.20M
Net Income2.66K7.29M

Balance Sheet

Currency: USD2024-12-312025-12-31
Total Assets195.25M203.11M
Total Liabilities7.75M8.32M
Total Equity187.50M194.79M
Cash1.36M1.43M
Total Debt11.82K11.82K
Net Debt-1.35M-1.42M

Cash Flow

Currency: USD2024-12-312025-12-31
Operating Cash Flow-89.69K-422.08K
Investing Cash Flow-191.99M500.00K
Financing Cash Flow193.44M0
Capital Expenditure30
Free Cash Flow-179-422.08K
FCF to OCF0.20%100.00%

Earnings

Report DateOct 4, 2024Dec 31, 2024May 14, 2025Aug 12, 2025Nov 13, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate0.00-------
EPS Actual-0.010.060.070.080.080.070.060.07
Surprise--------
Timing--------

Key Statistics & Ratios

Market Cap265.00M
Enterprise Value263.10M
Trailing P/E38.50
Forward P/E0.00
Price / Sales0.00
Price / Book1.34
EPS0.28
Book Value-0.305
Revenue (TTM)0
Gross Profit (TTM)0
Profit Margin0.00%
Operating Margin0.00%
Return on Equity0.00%
Return on Assets-0.38%
Shares Outstanding19.78M
Shares Float18.46M
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
97.24%
Insiders
0.00%
Retail / Other
2.76%

Top Institutional Holders

  • Cnh Partners, LLC
    1.32M5.39%
  • Decagon Asset Management LLP
    1.00M4.08%
  • Fort Baker Capital Management LP
    1.00M4.07%
  • Empyrean Capital Partners, LP
    900.00K3.66%
  • D. E. Shaw & Co LP
    861.63K3.50%
  • Boussard & Gavaudan Assets
    720.00K2.93%
  • Linden Advisors LLC
    600.00K2.44%
  • OZ Management LLC
    530.81K2.16%
  • The Goldman Sachs Group Inc
    529.53K2.15%
  • Moore Capital Management, LP
    525.00K2.14%
  • LMR Partners LLP
    510.90K2.08%
  • HighTower Advisors, LLC
    510.84K2.08%
  • Alberta Investment Management Corp
    500.00K2.03%
  • The Toronto-Dominion Bank
    496.65K2.02%
  • Ghisallo Capital Management LLC
    450.00K1.83%
  • HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND
    450.00K1.83%
  • Two Sigma Investments LLC
    437.50K1.78%
  • Gritstone Asset Management LLC
    394.91K1.61%
  • Radcliffe Group Inc
    382.44K1.56%
  • K2 PRINCIPAL FUND LP
    365.90K1.49%